Arbor Biotechnologies

Description

Develops gene editing treatments and genetic medicines using programmable DNA editors for people with genetic diseases, with a focus on CNS therapeutics.

Arbor Biotechnologies is located in the Boston ecosystem.

Related

• Prime Medicine ($PRME)Develops one-time genetic therapies using prime editing to locate genome targets and replace faulty DNA segments for patients with diseases…
• Editas Medicine ($EDIT)Develops CRISPR-based gene editing medicines, including in vivo approaches, for people with serious diseases where modifying genes may…
• Dyno TherapeuticsBuilds high-performance genetic technologies to improve AAV gene delivery for gene therapy, supporting therapeutic developers working on…
• Capsida BiotherapeuticsDevelops targeted genetic medicines and engineered capsids for neurological and ocular diseases, including IV-delivered CNS gene therapies…
• Generate BiomedicinesDevelops programmable protein-based medicines using generative biology, with clinical development and IND work focused on immunology and…
• Beam Therapeutics ($BEAM)Develops investigational base-editing genetic medicines and delivery technologies, including electroporation, nonviral, and viral methods,…
• Vertex Pharmaceuticals ($VRTX)Discovers, develops, and produces medicines for people with serious diseases, while offering treatment support and information about…
• Relay Therapeutics ($RLAY)Develops small molecule medicines using computational and experimental protein-motion analysis, targeting previously hard-to-drug precision…
• Mammoth BiosciencesDevelops in vivo gene-editing therapeutics, engineers CRISPR-Cas systems and editing strategies, and provides CRISPR-based detection…
• AsimovBuilds an end-to-end genetic design platform combining synthetic biology and computational tools for biologics, cell therapy, and gene…
• Moderna ($MRNA)Develops mRNA medicines using a platform for designing, researching, and testing mRNA, with a focus on addressing infectious and serious…
• Krystal Biotech ($KRYS)Develops and delivers redosable genetic medicines, including VYJUVEK for dystrophic epidermolysis bullosa, using engineered HSV-1 vectors…